Twenty peeled ILM tissues from each group were further tested for antibody specificity using WB. For WB analysis, human ILMs were immersed in lysis buffer, phacofragmented, pelleted by centrifugation, and dissolved in 5× sodium dodecyl sulfate (SDS) sample buffer. The samples were boiled for 10 minutes and loaded onto 8% to 12% SDS gradient gels. Proteins were transferred onto a polyvinylidene fluoride (PVDF) membrane, and blots were labeled with antibodies to laminin (LS-C25105, 1:500; LifeSpan), collagen IV (ab6586, 1:1000; Abcam), α1 (IV) (ab189408, 1:1000; Abcam), α2 (IV) (LS-C119455, 1:500; LifeSpan), α3 (IV) (MAB7546, 1:250; RD, Minneapolis, MN, USA), α4 (IV) (LS-C374330, 1:400; LifeSpan), α5 (IV) (LS-C314274, 1:400; LifeSpan), α6 (IV) (LS-C382816, 1:1000; LifeSpan), GFAP (ab7260, 1:10,000; Abcam), or vimentin (ab8978, 1:1000; Abcam). WB data were obtained from four pairs each of IMH and MF eyes. The results for each ILM sample pair were reproduced at least three times.